Bearish
4
Neutral
7
Bullish
3
Bearish
15
Neutral
7
Bullish
24
Bearish
11
Neutral
0
Bullish
21
Investor Presentation
Q4 FY25
Investor Presentation
Q4 FY24
Investor Presentation
Q4 FY24
Investor Presentation
Q1 FY24
Investor Presentation
Q4 FY22
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.



Market Cap
₹ 980 Cr
P/E
19.97
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
980 Cr
Low Risk
20.0
30.8
0.3
3.4
1,235.00
596.05
Sales CAGR
1Y
20.52%
3Y
-6.72%
5Y
21.70%
10Y
19.26%
Profit CAGR
1Y
68.50%
3Y
-30.74%
5Y
36.46%
10Y
40.37%
ROE
TTM
16.91%
3Y
12.14%
5Y
23.62%
10Y
22.54%
ROCE
TTM
18.84%
3Y
18.33%
5Y
31.39%
10Y
30.20%
Performance
MARKET LEADER
Valuation
REASONABLE
Growth
SLUGGISH
Profitability
HIGH MARGIN
Technicals
Bullish
Risk
MODERATE RISK
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Turned 1 L into 41.80 L in last 5 Years